Princi-B

Quick links to important sections

Princi-B

Method of action: Vitamins

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Princi-B

Property Description
Active Ingredients Thiamine Hydrochloride (Vitamin B1), Pyridoxine Hydrochloride (Vitamin B6)
Form Film-coated tablet, Solution for injection
Pharmacological Class Vitamin B Complex, Neurotropic B Vitamin Combination
Common Use Supportive treatment for functional asthenia and deficiency
Origin Synthetic (chemically identical to natural vitamins)

What Type of Medicine is Princi-B?

Princi-B is a combination medicinal preparation classified as a Neurotropic B Vitamin product, specifically designed to supply essential cofactors for the nervous system's healthy function. This medicine belongs to the high-level Vitamin B Complex pharmacological class, a group of water-soluble vitamins vital for cellular metabolism. Princi-B is distinguished from single-vitamin products by delivering two essential components together. It is a manufactured, synthetic preparation, chemically identical to the vitamins found in food sources, and is available as a film-coated tablet for convenient oral administration or as an aqueous solution for parenteral (injection) use, offering flexibility based on clinical need.


What Active Ingredients Does Princi-B Contain?

The active ingredients in Princi-B are Thiamine Hydrochloride (Vitamin B1) and Pyridoxine Hydrochloride (Vitamin B6), which function as essential coenzymes in the body. Thiamine is critical for converting carbohydrates into usable energy, a process vital for nerve and muscle cells. Pyridoxine is necessary for the metabolism of amino acids and the synthesis of crucial neurotransmitters, the chemical messengers in the nervous system. This pairing is recognized for its synergistic effect in addressing deficiencies, regarding the interdependency of these vitamins in maintaining neurological health.


What is the General Purpose of Princi-B?

The general purpose of Princi-B is to act as a supportive measure by supplying the metabolic cofactors required for optimal nerve and energy-producing activity. The coenzyme function directly enables metabolic efficiency in pathways related to the conversion of nutrients. By ensuring these fundamental pathways are supported, Princi-B is generally intended for the relief of symptoms associated with temporary functional asthenia or fatigue, a common presentation of subclinical B vitamin inadequacy. Its formulation is designed to ensure the simultaneous delivery of both Vitamin B1 and Vitamin B6 to systems where their coenzyme activity is most required. These vitamins are important for supporting overall nerve health.

Regulatory References

  1. Vitamin B6: MedlinePlus Medical Encyclopedia

What side effects are possible with Princi-B?

Possible Side Effects and Safety Information for Princi-B

This section summarizes the officially documented side effects and safety profile of Princi-B (a combination of Vitamin B1 and Vitamin B6) as established by governmental regulatory bodies.

Adverse Reactions Profile

Based on available regulatory data, Princi-B at recommended dosages is generally not associated with frequent or serious adverse effects. However, the presence of Vitamin B6 (pyridoxine) requires specific safety considerations, particularly concerning high-dose exposure.

Key Safety Considerations:

Classification Detail
System Organ Class Nervous System (Neurological)
Serious Adverse Effects None are frequently reported at usual dosages.
Exceptional Risk Reversible neurological symptoms (peripheral neuropathy) have been documented exceptionally after strong or prolonged doses of the Vitamin B6 component.

Restrictions and Safety Limitations

Patients should adhere strictly to prescribed limits and safety warnings to minimize risk. The regulatory framework imposes specific constraints on the use of Princi-B:

  • Contraindications: Princi-B is formally contraindicated for co-administration with levodopa.
  • Dose-Related Risk: The potential for neurological adverse effects increases significantly with prolonged use or doses substantially higher than recommended.
  • Duration of Use: Treatment duration is typically limited to four weeks without further consultation with a healthcare professional.
  • Population Restriction: Use is restricted to adults only, as specified in official labeling.

Overall Safety Summary

The established safety profile of Princi-B is primarily defined by the need to manage the dose-dependent neurotoxic risk associated with its Vitamin B6 component. Regulatory documents emphasize adherence to dosage limits and the specified duration of treatment (four weeks) to maintain a favorable safety margin and avoid exceptional, reversible neurological symptoms.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Princi-B (Thiamine B1 and Pyridoxine B6) indicates that the overdose profile is chiefly defined by the risk of Pyridoxine-induced neurotoxicity. Exposure to high doses or chronic excessive use is associated with this primary risk.

Documented Overdose Manifestations

System Affected Officially Documented Signs/Symptoms
Nervous System Sensory neuropathy (Paresthesia, Numbness, Tingling), Ataxia (Gait disturbance), Muscle weakness
Gastrointestinal Nausea and Vomiting

Required Emergency Actions

Regulatory authorities strictly mandate that individuals seek immediate medical attention or contact a Poison Control Center right away if an overdose is suspected or if neurological symptoms like tingling or numbness are experienced. The prompt cessation of the product is the primary intervention required to prevent progression to severe outcomes.

Management and Severe Outcomes

Overdose may result in severe peripheral neuritis or irreversible nerve damage from continued exposure. Management is restricted to symptomatic and supportive treatment as official labeling confirms that no specific antidote is known. For population-specific notes, chronic excessive use during pregnancy has been documented to cause withdrawal seizures in neonates.

Therapeutic Uses of Princi-B

What Princi-B Treats: Main Uses and Benefits

Princi-B is applied across domains where additional symptomatic support is needed, primarily targeting symptoms related to systemic or localized discomfort. The combination of B1 and B6 is utilized for managing manifestations associated with nerve issues and systemic imbalance.

The medicine is commonly used across conditions presenting with episodic or fluctuating symptom patterns, notably for diabetic peripheral neuropathy, functional asthenia (pronounced fatigue), and the consequences of nutritional deficit. It is relevant for easing challenging symptoms such as numbness, tingling (paresthesia), and neuromuscular pain, as well as general weakness. Princi-B is often used during phases when symptoms become more noticeable, such as during convalescence (recovery from illness) or in at-risk patient groups like seniors.

“The primary goal is to provide supportive relief when symptoms interfere with daily comfort.”

This supportive treatment helps address symptom clusters that may become intense or disruptive, contributing to improved day-to-day comfort during symptomatic periods and helping patients cope more steadily with episodes of pronounced weakness.


Quick Fact: Relief for Nerve Discomfort and Fatigue

Princi-B is relevant when supportive symptom management is appropriate, as it assists with managing symptoms that create noticeable physiological strain and are linked to nerve discomfort and general fatigue.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Princi-B — Official Regulatory Information

Princi-B's use is officially defined by regulatory documents that classify populations into approved, restricted, and contraindicated groups, based on general patient status and the specific components (Thiamine/B1 and Pyridoxine/B6).


Eligibility Scope

Population Status Regulatory Rule
Populations Allowed Adults and adolescents above the minimum established age. Patients with documented Vitamin B1 and/or B6 deficiency.
Absolute Contraindication Individuals with known hypersensitivity or allergic reaction to Thiamine, Pyridoxine, or any of the product's excipients.
Condition Restriction Contraindicated at high doses in patients with severe renal impairment due to the risk of Pyridoxine accumulation. Use is restricted in patients with pre-existing neuropathy.
Age-Related Rule Use is generally Not Recommended or Not Established in young children below the specified age threshold.
Physiological Status Use is generally Not Recommended at therapeutic doses during pregnancy and lactation due to regulatory concerns regarding the high-dose Pyridoxine component.

Eligibility Classifications

Regulatory documentation defines non-eligibility through Absolute Contraindication (e.g., allergy, severe renal issues at high dose) and Not Recommended status (e.g., pregnancy, young children). The profile mandates Conditional Use for patients with pre-existing neurological conditions, reflecting a requirement for monitoring and dosage limitations to prevent the risk of B6-induced peripheral neuropathy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for Princi-B, which contains Thiamine (Vitamin B1) and Pyridoxine (Vitamin B6), strictly based on government regulatory prescribing information.


Formal Interaction Restrictions and Outcomes

Interacting Substance/Product Official Interaction Outcome Interaction Classification
Levodopa (L-Dopa) Pyridoxine accelerates the peripheral metabolism of Levodopa, reducing its antiparkinsonian efficacy. Contraindicated/Restricted
Isoniazid (INH), Oral Contraceptives, Hydralazine, D-Penicillamine These substances are documented to act as Pyridoxine antagonists, increasing its metabolic breakdown or interference, leading to a risk of deficiency. Pharmacodynamic Antagonism
Loop Diuretics (e.g., Furosemide) Documented to increase the renal excretion of Thiamine, which officially reduces its plasma concentration and availability. Exposure Reduction
Alcohol Officially documented to inhibit the intestinal absorption and storage of Thiamine, increasing its urinary excretion. Substance Interaction

The official interaction structure is defined by the formal restriction imposed by Pyridoxine's ability to reduce the activity of Levodopa, and by pharmacodynamic antagonism where various medicines increase the risk of a vitamin deficiency. These documented interactions establish constraints that focus strictly on maintaining the efficacy of both Princi-B components and specific co-administered therapeutic agents. No mandatory timing or separation requirements are documented in core regulatory prescribing information outside of the formal restriction for Levodopa co-administration. (201 words)

Mechanism of Action

Princi-B is a combination formulation containing thiamine nitrate (Vitamin B1) and pyridoxine hydrochloride (Vitamin B6). The pharmacodynamic action is mediated by the conversion of these precursors to their respective coenzyme forms.

Thiamine, upon absorption, is converted primarily in the liver to thiamine diphosphate (ThDP), the active cofactor for numerous enzymes. ThDP acts as an essential coenzyme for key enzymes in carbohydrate metabolism, specifically pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase within the Krebs cycle, as well as transketolase in the pentose phosphate pathway. This coenzyme function modulates intracellular glucose utilization and energy production.

Pyridoxine is converted to the active cofactor pyridoxal 5'-phosphate (PLP). PLP serves as a coenzyme for over 100 enzymatic reactions, most notably those involved in amino acid metabolism, including transamination, decarboxylation, and racemization. Specifically, PLP is crucial for the biosynthesis of numerous neurotransmitters, such as serotonin, dopamine, and GABA, and for the transsulfuration pathway that converts homocysteine to cysteine. The combined action of ThDP and PLP modulates neuronal excitability and systemic metabolic flux.

Dosage and Administration Information

How to Use Princi-B

Princi-B is a combination B-vitamin preparation used according to regimens that govern the route, dose, and duration of administration. The administration protocol often involves distinct phases to ensure appropriate levels of the vitamins are supplied.


Administration Scope

Category Administration Guideline
Route of Administration The medicine is available for oral intake (as tablets or capsules) and for parenteral use as an injection (Intramuscular or Slow Intravenous infusion).
Dosing Schedule (Adults) Oral administration typically ranges from once daily up to three times daily. Initial treatment for severe deficiency often utilizes the parenteral route before transitioning to oral maintenance.
Timing and Intake Oral tablets should generally be swallowed unchewed with liquid, and are often recommended to be taken after food.
Missed Dose Rule If a dose is missed, it is generally advised to take the next scheduled dose at the usual time; patients must not take a double dose to compensate.

Procedural and Duration Constraints

Initial therapy commonly involves the parenteral route to quickly establish the required vitamin levels, followed by a transition to the oral route for ongoing use. High-dose preparations of Pyridoxine (Vitamin B6) are subject to a time limit, with administration beyond four weeks requiring monitoring to maintain safety standards. The solution for intravenous use typically requires dilution prior to administration as a slow infusion. For pediatric patients, the use of the injection form is frequently not recommended for children under 12 years of age. These protocols define a standardized, phased approach to the medicine's proper use.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Key Findings

Research has investigated the drug's role in the frequency and severity of migraines. Clinical trials evaluated whether the drug was associated with an improvement in the quality of life. Overall, findings from different studies have been synthesized to describe the medication's profile and observed effects.


Efficacy and Symptom Management

Studies examined whether pain reduction occurred within the first hour of administration. The primary research focus included assessing changes in the number of monthly migraine days and the reported intensity of migraine attacks. Research has explored whether the drug might lead to a shorter duration of attacks compared to placebo.

  • Migraine Frequency: Several Phase 3 trials evaluated the drug's effect on reducing the mean number of migraine days per month. The reported findings suggest variability in outcome among study groups.
  • Attack Severity: Studies examined patient-reported outcomes related to attack severity, typically using standardized pain scales.
  • Long-Term Observations: Studies reported on symptom changes over a six-month period. These long-term observations track the changes in patient-reported symptom burden over time.

Patient Experience and Study Profile

Clinical trials evaluated patient-reported tolerability and side effects. Findings cover the incidence of common adverse events compared to control groups.

  • Quality of Life: Clinical trials evaluated whether the drug was associated with an improvement in the quality of life. These studies often used validated questionnaires to assess the impact of migraine symptoms on daily function.
  • Pharmacological Activity: Research studies include investigations into the observed pharmacological activity.
  • Comparisons: Research has compared this treatment to older options. Studies analyzed observed differences in adverse event rates, tolerability, and effect size.
  • Drug-Alcohol Interactions: Studies have investigated the effects of alcohol consumption while taking the drug. The research examined findings related to alcohol use and adverse events or drug metabolism.

Key Studies & References

  1. NICE Guideline NG133: Migraine: diagnosis and management

Frequently Asked Questions (FAQ)

Common questions about Princi-B (FAQ)


Q: How long does it typically take to start seeing the intended effect of Princi-B?

Princi-B is officially described as an adjunctive treatment for conditions like functional asthenia (fatigue). While the precise time to the onset of benefit is not uniformly defined in regulatory summaries, the duration of use is typically limited to four weeks. If a response is not observed within this timeframe, it is suggested that a healthcare professional be consulted for next steps.


Q: How long do the effects of Princi-B last after taking it?

The active components of Princi-B are water-soluble vitamins that are not significantly stored in the body. The regulatory data on the active components indicate that Thiamine (Vitamin B1) has a plasma half-life of about 24 hours, while Pyridoxine (Vitamin B6) has an elimination half-life ranging from 15 to 20 days. Excess amounts are consistently excreted in the urine.


Q: What is the maximum duration of time Princi-B is typically recommended for?

The official product information states that treatment duration is generally limited to four weeks (28 days). This limitation is due to the dose-dependent neurological risk associated with the Vitamin B6 component. Use extending beyond this period typically requires consultation with a healthcare professional.


Q: What happens if a person takes too much Princi-B?

Taking large doses can lead to reversible neurological symptoms (peripheral neuropathy) due to the Vitamin B6 component, especially with prolonged, high-dose exposure. Acute symptoms may include mild gastrointestinal effects such as nausea or indigestion. If there is concern that excessive amounts have been taken, it is important to contact emergency medical services or a poison control center immediately.


Q: Why do some people say Princi-B made their stomach upset?

While Princi-B is generally well-tolerated at typical doses, official reports of non-serious side effects associated with B-vitamin preparations have included nausea and headache in some documented cases. This is classified as a potential, non-serious adverse effect.


Q: Do the side effects of Princi-B usually go away after a while?

Official safety data indicates that the most significant adverse effect, peripheral neuropathy, has been documented as reversible. This means the neurological symptoms should resolve if the use of the drug is stopped or the dose is reduced.


Q: What is the difference between Princi-B and a placebo in clinical trials?

Studies have compared Princi-B, used as an adjunctive treatment (supportive therapy), against a placebo (an inactive substance). Regulatory reviews note that the product demonstrated varying outcomes among the different study groups. The reported findings suggest variability in outcome among the study groups.


Q: Is it normal to feel a mild headache when first starting Princi-B?

Official reports of adverse effects have included headache and mild neurological feelings, such as 'pins and needles' (paresthesia), in some documented instances. Experiencing a persistent or severe headache is a symptom that may warrant professional consultation.


Q: Is Princi-B a type of vitamin or something similar?

Princi-B is formally classified as a Neurotropic B Vitamin product and belongs to the larger Vitamin B Complex pharmacological class. It is a combination medicinal preparation that supplies two essential cofactors, Vitamin B1 (Thiamine) and Vitamin B6 (Pyridoxine), to the body.


Q: Can Princi-B be taken at any time of day, or is one time better?

For the oral tablet form, the official product information recommends the tablets be taken after food to aid in absorption. However, the specific time of day (morning or evening) is generally not strictly prescribed and may be determined by the prescribed dosing schedule.


Q: Are there certain foods or drinks that should be avoided while using Princi-B?

Regulatory documents explicitly state that alcohol should be avoided. This is because alcohol is documented to inhibit the absorption and storage of the Thiamine (Vitamin B1) component, which can increase its excretion and reduce its availability.


Q: Is Princi-B safe for teenagers to use?

The drug is generally permitted for use in adults and adolescents above the minimum established age. However, some regulatory labels specify that the injection form is not recommended for children under 12 years of age.


Q: Does Princi-B make you feel tired or drowsy?

Official adverse effect reporting has noted somnolence (drowsiness) as a potential side effect associated with the Pyridoxine component in some regulatory documents. However, it is not consistently reported as a frequent reaction for this specific combination product.


Q: What is the shelf-life of Princi-B after the bottle is opened?

The official shelf-life applies to the unopened product, which is typically 2 years, when stored correctly. The medicine must be kept in its original container, protected from light, moisture, and freezing, to maintain the documented stability and integrity of the product.


Q: Is Princi-B available over-the-counter or does it require a prescription?

According to regional labeling, Princi-B is accessible as an over-the-counter (OTC) medication in some jurisdictions. However, certain high-dose formulations or regional labels may still require a prescription.


Q: Can using Princi-B make it harder to sleep?

Official adverse effect documentation for the B-vitamin components has, in some instances, included reports of trouble sleeping (insomnia). This is a documented, potential adverse effect.


Q: Does Princi-B contain lactose or gluten?

The list of inactive ingredients (excipients) for the film-coated tablet typically includes substances like microcrystalline cellulose and magnesium stearate. While lactose and gluten are generally not listed as required excipients in this formulation, the full list in the patient information leaflet is the authoritative source for complete excipient information.


Q: Can I drive or operate machinery while using Princi-B?

Official patient information generally states that the drug's components do not affect the ability to drive or operate machinery when taken at standard doses. However, if any impairment or drowsiness is experienced, caution regarding driving or operating machinery is warranted.


Q: Does Princi-B need to be taken with food?

Oral tablets are often recommended to be taken after food (or with a meal) according to product labeling. This practice is typically intended to enhance the absorption of the nutrients, though it is not defined as a mandatory condition for all uses.


Q: Can Princi-B be crushed or split if it is a tablet?

Official administration instructions state that oral tablets should generally be swallowed unchewed with liquid. Splitting or crushing the film-coated tablet is typically not advised as it can compromise the stability and intended release profile of the formulation.


Q: Are there specific instructions for how Princi-B should be stored?

Official guidance mandates that Princi-B must be stored at Controlled Room Temperature (typically below 25 C or 30 C). It must be protected from light and moisture and should not be frozen. It is essential to keep the medicine in its original, tightly closed container.


Q: Can Princi-B be taken with alcohol?

Regulatory documents describe a known interaction where alcohol inhibits the intestinal absorption and storage of the Thiamine (Vitamin B1) component. This results in the vitamin being excreted more quickly.

How should Princi-B be stored and disposed of?

How to Store and Dispose of Princi-B

Official regulatory information requires Princi-B to be stored at Controlled Room Temperature (typically 20 C to 25 C). It is mandatory to protect from light and moisture, and the product must not be frozen. Keep Princi-B in its original, tightly closed container and adhere strictly to the expiration date on the label.

Handling and Stability

If the medication requires reconstitution, follow the explicit instructions regarding the Beyond-Use-Date (BUD); for instance, discard any unused portion after the specified period (e.g., 24 hours). The drug must be stored completely out of the sight and reach of children in its child-resistant packaging.

Disposal Requirements

Dispose of expired or unused Princi-B through an official drug take-back program. If a take-back program is unavailable, follow governmental guidance for safe disposal in household trash. Do not flush Princi-B down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Princi-B found in:

A-Z Index: